FMO5 and obstructive sleep apnea syndrome: The principal investigator of this clinical trial previously demonstrated that NADPH oxidase activation is directly related to arterial endothelial dysfunction and that OSA-related NADPH oxidase-generated oxidative stress can be partially reversed by nasal continuous positive airway pressure treatment (CPAP).